| ADR Ontology |
| ADR Term |
Adverse drug reaction |
| ADR ID |
BADD_A05962 |
| ADR Hierarchy |
|
| Description |
Disorders that result from the intended use of PHARMACEUTICAL PREPARATIONS. Included in this heading are a broad variety of chemically-induced adverse conditions due to toxicity, DRUG INTERACTIONS, and metabolic effects of pharmaceuticals. [MeSH] |
| MedDRA Code |
10061623 |
| MeSH ID |
D064420; D064420; D064420
|
|
ADR Severity Grade (FAERS)
|
|
|
ADR Severity Grade (CTCAE)
|
Not Available
|
| Synonym |
| Adverse drug reaction NOS | Adverse drug reaction | Drug side effect | Drug-Related Side Effects and Adverse Reactions | Drug Related Side Effects and Adverse Reactions | Side Effects of Drugs | Drug Side Effects | Drug Side Effect | Effects, Drug Side | Side Effect, Drug | Side Effects, Drug | Adverse Drug Reaction | Adverse Drug Reactions | Drug Reaction, Adverse | Drug Reactions, Adverse | Reactions, Adverse Drug | Adverse Drug Event | Adverse Drug Events | Drug Event, Adverse | Drug Events, Adverse | Drug Toxicity | Toxicity, Drug | Drug Toxicities | Toxicities, Drug |
|
|
| ADR Related Proteins |
| Protein Name |
UniProt AC |
TTD Target ID |
| Alanine aminotransferase 1 | P24298 | Not Available | | Alkaline phosphatase, placental type | P05187 | Not Available | | ATP-binding cassette sub-family C member 9 | Q63563 | Not Available | | Brain-derived neurotrophic factor | P21237 | Not Available | | Brain-derived neurotrophic factor | P23560 | T93122 | | Brain-specific angiogenesis inhibitor 1-associated protein 2-like protein 1 | Q9UHR4 | Not Available | | Cocaine esterase | O00748 | Not Available | | Cytochrome P450 1A2 | P05177 | Not Available | | Cytochrome P450 2B1 | P00176 | Not Available | | Cytochrome P450 2B6 | P20813 | T11793 | | Cytochrome P450 2C19 | P33261 | Not Available | | Cytochrome P450 2D6 | P10635 | T57392 | | Cytochrome P450 2E1 | P05181 | Not Available | | Cytochrome P450 3A4 | P08684 | T37848 | | Delta-type opioid receptor | P41143 | T58992 | | Erythroagglutinating phytohemagglutinin | P05088 | Not Available | | G protein-activated inward rectifier potassium channel 1 | P48549 | T38012 | | Gamma-tubulin complex component 3 | Q96CW5 | Not Available | | Glial fibrillary acidic protein | P14136 | Not Available | | Inosine triphosphate pyrophosphatase | Q9BY32 | Not Available | | Interleukin-6 | P05231 | T32578 | | Interleukin-8 | P10145 | T22658 | | Kappa-type opioid receptor | P41145 | T60693 | | Methionine aminopeptidase 1 | P53582 | T42337 | | Muscarinic acetylcholine receptor | Q53XZ3 | Not Available | | Nuclear receptor subfamily 4 group A member 3 | Q92570 | T93949 | | Parathyroid hormone/parathyroid hormone-related peptide receptor | Q03431 | T67710 | | Poly(A) polymerase alpha | P25500 | Not Available | | Prostacyclin synthase | Q16647 | T83979 | | Prostaglandin G/H synthase 1 | P23219 | T60529 | | Protein c-Fos | P01100 | T28025 | | S-adenosylhomocysteine hydrolase-like protein 1 | O43865 | Not Available | | Solute carrier family 2, facilitated glucose transporter member 1 | P11166 | T89458 | | Solute carrier family 2, facilitated glucose transporter member 2 | P11168 | Not Available | | T-cell surface glycoprotein CD3 epsilon chain | A6H6M1 | Not Available | | Thiopurine S-methyltransferase | P51580 | Not Available | | Tumor necrosis factor | P01375 | T20178 |
|
| Drugs Leading to the ADR |
|
|
